Dual Chamber Injection Devices to 2024


dual chamber injection devices   Dual Chamber Injection Devices • December 2017 •  no. DCJ434K  •  US $2,850


The need to reconstitute lyophilized drugs at the point of administration and the potential safety and compliance issues this represents for patients has led to increasing interest in injection devices that can eliminate the number of steps required to reconstitute the drug and make it available for injection. Dual chamber syringes and injectors – devices that allow reconstitution to take place within the device immediately prior to injection – represent the most elegant engineering solution to this need. While the use of dual chamber devices represents a cost premium for drug marketers relative to competing reconstitution methods such as vial adaptors, it also provides an opportunity for branding. In terms of market penetration, dual chamber injection devices can be found in seven distinct therapeutic segments. We expect this number to grow as the influence of injectable biologicals on therapeutic practice increases. As biological drugs continue to grow in terms of therapeutics and total prescriptions, the impact of these specialty devices will increase, reaching a therapeutic market value of $5.3 billion annually in 2024.

     Dual Chamber Syringes & Injectors Report Brochure (Download PDF)

Bar_Graph     Dual Chamber Syringes & Injectors Report Order Form (Download PDF)

 


Dual Chamber Injection Devices – What You Will Learn

• What are the currently marketed dual chamber syringes and injection devices and what is their impact on markets for therapeutic injectable lyophilized drugs?

• What are the currently marketed dual chamber syringes and injection devices and what is their impact on markets for therapeutic injectable lyophilized drugs?

• What are the therapeutic demand drivers for user-friendly point-of-use reconstitution devices and what specifically is the potential of dual chamber syringes and injector systems?

• What are the key dual chamber device selection factors, technologies and market development issues?

• What doses the current dual chamber device market look like, who are the market leaders, and what will this market look like in 2024?

• What companies supply dual chamber syringe and injector devices, and what are their product activities, business strategies, and corporate alliances and affiliations?

• How important are pharma-device alliances and design partnerships on dual chamber injection devices?

• What is the impact of economic, technology, and regulatory factors?


Dual Chamber Injection Devices – Summary of Contents

Executive Summary
Specialty Injection Device Market Dynamics
Drug Formulation Evolution
Specialty Injection Device Demand Drivers
Chronic Conditions and Self-Administration
The Growth of Biologicals
Shifting Patient Demographics
Drug Economics, Safety and Compliance
Device Design and Innovation
Competitive Landscape
Technology Market Drivers

The Dual Chamber Injection Device Analysis
Dual Chamber Cartridges
Branded Devices
Supply Chain
Commercial Drug Products
Dual Chamber Injectors
Branded Devices
Supply Chain
Commercial Drug Products
Dual Chamber Syringes
Branded Devices
Supply Chain
Commercial Drug Products
Product-Specific Devices
Product Specific Device Development
Specialty Devices
OEM Devices

Dual Chamber Therapeutic Segments – Market Data & Forecasts
Glycemic Control
Hereditary Conditions
Hormone Replacement
Infectious Disease
Metabolic Conditions
Oncology
Reproductive Health
Other Therapeutic Segments

Market Factors
Device Product Strategies
Device Economics
Product Branding
Direct-to-Consumer Marketing
Managed Care Trends

Company Profiles

 


Useful Links: